• Entity registrant name: ISRAEL CHEMICALS LTD. (CIK: 0000941221)
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/941221/000095010318003092/0000950103-18-003092-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/941221/000095010318003092/icl-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • XBRL Cloud Rendering (requires license): Click to open XBRL Cloud Component Rendering
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0000941221
  • Open this page in separate window: Click

    • * * *

    Component: (Network and Table)
    Network
    00200 - Statement - Consolidated Statements of Income
    (http://www.icl-group.com/role/ConsolidatedStatementsOfIncome)
    Table (Implied)
    Slicers (applies to each fact value in each table cell)
    Reporting Entity [Axis] 0000941221 (http://www.sec.gov/CIK)
    Statements of Income [Abstract] Period [Axis]
    2017-01-01 - 2017-12-31
    2016-01-01 - 2016-12-31
    2015-01-01 - 2015-12-31
    Statements of Income [Abstract]
     
     
     
    Sales
    5,418,000,000  
    5,363,000,000  
    5,405,000,000  
    Cost of sales
    3,746,000,000  
    3,703,000,000  
    3,602,000,000  
    Gross profit
    1,672,000,000  
     
    1,660,000,000  
     
    1,803,000,000  
     
    Selling, transport and marketing expenses
    746,000,000  
    722,000,000  
    653,000,000  
    General and administrative expenses
    261,000,000  
    321,000,000  
    350,000,000  
    Research and development expenses
    55,000,000  
    73,000,000  
    74,000,000  
    Other expenses
    90,000,000  
    618,000,000  
    211,000,000  
    Other income
    (109,000,000) 
    (71,000,000) 
    (250,000,000) 
    Operating income (loss)
    629,000,000  
     
    (3,000,000) 
     
    765,000,000  
     
    Finance expenses
    229,000,000  
    157,000,000  
    160,000,000  
    Finance income
    (105,000,000) 
    (25,000,000) 
    (52,000,000) 
    Finance expenses, net
    124,000,000  
     
    132,000,000  
     
    108,000,000  
     
    Share in earnings of equity-accounted investees
    0  
    18,000,000  
    11,000,000  
    Income (loss) before taxes on income
    505,000,000  
     
    (117,000,000) 
     
    668,000,000  
     
    Provision for income taxes
    158,000,000  
    55,000,000  
    162,000,000  
    Net income (loss)
    347,000,000  
     
    (172,000,000) 
     
    506,000,000  
     
    Net loss attributable to the non-controlling interests
    (17,000,000) 
    (50,000,000) 
    (3,000,000) 
    Net income (loss) attributable to the shareholders of the Company
    364,000,000  
     
    (122,000,000) 
     
    509,000,000  
     
    Earnings (loss) per share attributable to the shareholders of the Company
     
     
     
    Basic earnings (loss) per share (in $)
    .29  
    (.10) 
    .40  
    Diluted earnings (loss) per share (in $)
    .29  
    (.10) 
    .40  
    Weighted-average number of ordinary shares outstanding
     
     
     
    Basic (in thousands)
    1,276,072,000  
    1,273,295,000  
    1,271,624,000  
    Diluted (in thousands)
    1,276,997,000  
    1,273,295,000  
    1,272,256,000